10-Q Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001179929-18-000145`
Period End Date	20180630
Filing Date	20180801
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	moh-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 82 Cash Flow Statement 84 Stockholders Equity 24 Comprehensive Income 20

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.39B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.98B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.19B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	60.00M	shares	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$2.52B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	62.00M	shares	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$2.18B	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsCurrent`	$169.00M	USD	Point-in-time
Preferred stock, par value (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsCurrent`	$80.00M	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$871.00M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.15B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$239.00M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$344.00M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Derivative asset	`DerivativeAssetsCurrent`	$657.00M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Derivative asset	`DerivativeAssetsCurrent`	$522.00M	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$230.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.03B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.51B	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentNet`	$342.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentNet`	$276.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$255.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$201.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$119.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$117.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$103.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$114.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$28.00M	USD	Point-in-time
Total assets held for sale	`Assets`	$8.47B	USD	Point-in-time
Total assets held for sale	`Assets`	$8.76B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.19B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.93B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.08B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.92B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$1.75B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$1.54B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$754.00M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$366.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$193.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$282.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$484.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$653.00M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$657.00M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$522.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$66.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.82B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.56B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.02B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.32B	USD	Point-in-time
Lease financing obligations	`CapitalLeaseObligationsNoncurrent`	$198.00M	USD	Point-in-time
Lease financing obligations	`CapitalLeaseObligationsNoncurrent`	$198.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$61.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$68.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.11B	USD	Point-in-time
Total liabilities	`Liabilities`	$7.13B	USD	Point-in-time
Common stock, $0.001 par value, 150 shares authorized; outstanding: 62 shares at June 30, 2018 and 60 shares at December 31, 2017	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value, 150 shares authorized; outstanding: 62 shares at June 30, 2018 and 60 shares at December 31, 2017	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.05B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-11.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$614.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$298.00M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.34B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.66B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.47B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.76B	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$114.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$106.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$225.00M	USD	2 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$210.00M	USD	2 Qtrs
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$165.00M	USD	2 Qtrs
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$104.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	2 Qtrs
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$56.00M	USD	2 Qtrs
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$30.00M	USD	2 Qtrs
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$16.00M	USD	1 Quarter
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$32.00M	USD	1 Quarter
Total revenue	`Revenues`	$9.53B	USD	2 Qtrs
Total revenue	`Revenues`	$9.90B	USD	2 Qtrs
Total revenue	`Revenues`	$5.00B	USD	1 Quarter
Total revenue	`Revenues`	$4.88B	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$405.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$844.00M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$335.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$687.00M	USD	2 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$106.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$210.00M	USD	2 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$114.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$225.00M	USD	2 Qtrs
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$174.00M	USD	2 Qtrs
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	2 Qtrs
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$99.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$37.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$51.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$76.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$25.00M	USD	1 Quarter
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	1 Quarter
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	$72.00M	USD	2 Qtrs
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	$72.00M	USD	1 Quarter
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	2 Qtrs
Restructuring and separation costs	`RestructuringCosts`	$43.00M	USD	2 Qtrs
Restructuring and separation costs	`RestructuringCosts`	$33.00M	USD	2 Qtrs
Restructuring and separation costs	`RestructuringCosts`	$234.00M	USD	Annual
Restructuring and separation costs	`RestructuringCosts`	$8.00M	USD	1 Quarter
Restructuring and separation costs	`RestructuringCosts`	$43.00M	USD	1 Quarter
Restructuring and separation costs	`RestructuringCosts`	$267.00M	USD	6 Qtrs
Total operating expenses	`CostsAndExpenses`	$10.11B	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$4.54B	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$8.96B	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$5.29B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-205.00M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-287.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$564.00M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$342.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$53.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$27.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$65.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$32.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$75.00M	USD	2 Qtrs
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$-15.00M	USD	2 Qtrs
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	1 Quarter
Total other expenses (income), net	`NonoperatingIncomeExpense`	$-27.00M	USD	1 Quarter
Total other expenses (income), net	`NonoperatingIncomeExpense`	$22.00M	USD	2 Qtrs
Total other expenses (income), net	`NonoperatingIncomeExpense`	$-37.00M	USD	1 Quarter
Total other expenses (income), net	`NonoperatingIncomeExpense`	$-80.00M	USD	2 Qtrs
Income (loss) before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$484.00M	USD	2 Qtrs
Income (loss) before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-183.00M	USD	2 Qtrs
Income (loss) before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$305.00M	USD	1 Quarter
Income (loss) before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-314.00M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$103.00M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-30.00M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-84.00M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$175.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$309.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-153.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-230.00M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-2.74	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.29	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-4.10	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$5.10	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.68	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.74	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-4.10	USD	1 Quarter

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-153.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-230.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$309.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$96.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$73.00M	USD	2 Qtrs
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	2 Qtrs
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	1 Quarter
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	$72.00M	USD	2 Qtrs
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	$72.00M	USD	1 Quarter
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$41.00M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$6.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$35.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$13.00M	USD	2 Qtrs
Non-cash restructuring costs	`NoncashRestructuringCharges`	-	USD	2 Qtrs
Non-cash restructuring costs	`NoncashRestructuringCharges`	$17.00M	USD	2 Qtrs
Amortization of convertible senior notes and lease financing obligations	`AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation`	$13.00M	USD	2 Qtrs
Amortization of convertible senior notes and lease financing obligations	`AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation`	$16.00M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-15.00M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$4.00M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$7.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$32.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$315.00M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$38.00M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$181.00M	USD	2 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$148.00M	USD	2 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-267.00M	USD	2 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$642.00M	USD	2 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$205.00M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-18.00M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$349.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-42.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-32.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-30.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$127.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$314.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$672.00M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$914.00M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$1.64B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.33B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$874.00M	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$60.00M	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$24.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$9.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$398.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-846.00M	USD	2 Qtrs
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	-	USD	2 Qtrs
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	$300.00M	USD	2 Qtrs
Repayment of 1.125% Convertible Notes	`PaymentsToAcquireNotesReceivable`	$89.00M	USD	2 Qtrs
Repayment of 1.125% Convertible Notes	`PaymentsToAcquireNotesReceivable`	-	USD	2 Qtrs
Cash paid for partial settlement of 1.125% Conversion Option	`CashPaidForSettlementOfConversionOption`	-	USD	2 Qtrs
Cash paid for partial settlement of 1.125% Conversion Option	`CashPaidForSettlementOfConversionOption`	$134.00M	USD	2 Qtrs
Cash received for partial termination of 1.125% Call Option	`ProceedsFromConvertibleDebt`	$134.00M	USD	2 Qtrs
Cash received for partial termination of 1.125% Call Option	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Cash paid for partial termination of 1.125% Warrants	`PaymentsForRepurchaseOfWarrants`	$113.00M	USD	2 Qtrs
Cash paid for partial termination of 1.125% Warrants	`PaymentsForRepurchaseOfWarrants`	-	USD	2 Qtrs
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfDebt`	-	USD	2 Qtrs
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfDebt`	$325.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$8.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.00M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$333.00M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-503.00M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$159.00M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$209.00M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.91B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.50B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.07B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.07B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.50B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.91B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Common stock used for share-based compensation	`StockIssued1`	$21.00M	USD	2 Qtrs
Common stock used for share-based compensation	`StockIssued1`	$6.00M	USD	2 Qtrs
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Common stock issued in exchange for 1.625% Convertible Notes	`NotesIssued1`	$131.00M	USD	2 Qtrs
Common stock issued in exchange for 1.625% Convertible Notes	`NotesIssued1`	-	USD	2 Qtrs
Component of 1.625% Convertible Notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	-	USD	2 Qtrs
Component of 1.625% Convertible Notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	$-23.00M	USD	2 Qtrs
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	2 Qtrs
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	2 Qtrs

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`SharesOutstanding`	56.00M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	61.00M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	59.00M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	56.00M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.66B	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-153.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-230.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$309.00M	USD	2 Qtrs
Partial termination of 1.125% Warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-113.00M	USD	2 Qtrs
1.625% Convertible Notes exchange transaction	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	2 Qtrs
1.625% Convertible Notes exchange transaction	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	2 Qtrs
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.00M	USD	2 Qtrs
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$2.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-5.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$16.00M	USD	2 Qtrs
Ending Balance (in shares)	`SharesOutstanding`	56.00M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	61.00M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	59.00M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	56.00M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.66B	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-153.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-230.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$309.00M	USD	2 Qtrs
Unrealized investment gain (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	-	USD	1 Quarter
Unrealized investment gain (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.00M	USD	1 Quarter
Unrealized investment gain (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.00M	USD	2 Qtrs
Unrealized investment gain (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-6.00M	USD	2 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	2 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-1.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-1.00M	USD	2 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$2.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-5.00M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-152.00M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$304.00M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$204.00M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-230.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.